Carregant...
Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration–Approved Duration
OBJECTIVE: To evaluate the effectiveness of the contraceptive implant and the 52mg hormonal intrauterine device (IUD) in women using the method beyond the current U.S. Food and Drug Administration–approved duration of 3 and 5 years respectively. METHODS: Women willing to continue using their implant...
Guardat en:
| Publicat a: | Obstet Gynecol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4347947/ https://ncbi.nlm.nih.gov/pubmed/25730221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000000690 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|